IDiyas

For the Inventor, By the Inventor

Darmstadt, Germany

Dieter Orth

USPTO Granted Patents = 24

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 147(Granted Patents)


Company Filing History:

goldMedal21 out of 1,248 
 
Merck Patent Gesellschaft MIT Beschrankter Haftung
 patents
silverMedal3 out of 100 
 
Merck Patent Gesellschaft MIT Beschraenkter Haftung
 patents

Years Active: 1976-1986

Loading Chart...
24 patents (USPTO):Explore Patents
1. 4622316 - 13-thiaprostaglandins having cytoprotective activity (1986-11-11),
2. 4617293 - Flavonoid phosphate salts of aminoglycoside antibiotics (1986-10-14),
3. 4309441 - 13-Thiaprostaglandin derivatives (1982-01-05),
4. 4289774 - Lipid lowering and anti-thrombotic 6-arylpyridazin-3-ones and a process (1981-09-15),
5. 4289768 - Phenothiazine derivatives and a process for their preparation (1981-09-15),
6. 4264585 - Hydrocortisone esters, pharmaceutical formulations containing these and (1981-04-28),
7. 4264584 - Hydrocortisone orthoesters, pharmaceutical formulations thereof and (1981-04-28),
8. 4258047 - Pyrazole derivatives, pharmaceutical formulations thereof (1981-03-24),
9. 4239759 - Morpholino containing compounds, compositions and use thereof (1980-12-16),
10. 4210651 - Thiaprostaglandins (1980-07-01),
11. 4209444 - New prostaglandin-like diketals (1980-06-24),
12. 4196215 - Alkyne compounds and method of use (1980-04-01),
13. 4188403 - Cyclopentan-1-amines (1980-02-12),
14. 4151302 - Araliphatic dihalogen compounds composition and method of use (1979-04-24),
15. 4151294 - Alkynols and process for their preparation (1979-04-24),

Title: The Innovative Contributions of Dieter Orth

Introduction: Dieter Orth, based in Darmstadt, Germany, is a prominent inventor with a remarkable portfolio consisting of 24 patents. His work significantly contributes to the fields of pharmaceuticals and biotechnology, showcasing a commitment to innovation that addresses critical health issues.

Latest Patents: Among his latest innovations, Orth has developed patents for 13-thiaprostaglandins, which exhibit cytoprotective activity. These specific 13-thiaprostaglandins follow a particular formula, providing potential therapeutic benefits. Additionally, he has created flavonoid phosphate salts of aminoglycoside antibiotics. These salts are recognized for their usefulness as sparingly soluble components, allowing for the achievement of depot effects in medicinal applications.

Career Highlights: Dieter Orth's career has been closely linked with significant pharmaceutical entities, particularly the Merck Patent Gesellschaft mit beschränkter Haftung. His contributions to these organizations have paved the way for numerous advancements in drug development and medical therapies, showcasing his expertise in the field.

Collaborations: Throughout his career, Dieter Orth has collaborated with notable colleagues such as Joachim Gante and Manfred Baumgarth. These partnerships have been essential in driving innovative research and development within the pharmaceutical sector.

Conclusion: Dieter Orth's enduring impact on innovation through his extensive patent portfolio illustrates his dedication to the advancement of medical science. His inventions continue to play a pivotal role in enhancing therapeutic options and improving patient outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…